Figure 2. Overall survival (Kaplan–Meier) for mRCC plotted againstthe response rates. The median overall survival was not reached forpatients whose best response was complete (CR), 45.9 months forpartial response (PR) (n=47, HR=1.54, 95%CI=1.20-1.91), 29.4months for stable disease (SD) (n=43, HR=0.94, 95%CI=0.73-1.21),and 4.9 months for progressive disease (n=34; HR=0.31, 95%CI=0.19-0.46, p<0.05).